Search research articles
Contact Us
Filters
Showing results (1041-1050 of 1,153) with videos related to
Page
of 116
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2017
Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group
Annette M Staiger, Marita Ziepert, Heike Horn, et al.
Nature Medicine
|
November 25, 2014
Disruption of the PRKCD-FBXO25-HAX-1 axis attenuates the apoptotic response and drives lymphomagenesis
Ursula Baumann, Vanesa Fernández-Sáiz, Martina Rudelius, et al.
Leukemia & Lymphoma
|
August 26, 2017
Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYC
Ulrike Paul, Julia Richter, Christiane Stuhlmann-Laiesz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 29, 2019
Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration
Joshua W D Tobin, Colm Keane, Jay Gunawardana, et al.
Mbio
|
April 30, 2026
The Guild Model of CF Airway Microbial Ecology
Sage J B Dunham, Gregory A Willkeen, Ben Darby, et al.
Genes, Chromosomes & Cancer
|
July 16, 2015
The PCBP1 gene encoding poly(rC) binding protein I is recurrently mutated in Burkitt lymphoma
Rabea Wagener, Sietse M Aukema, Matthias Schlesner, et al.
Leukemia
|
November 7, 2025
Cyclin D1 rearranged diffuse large B-cell lymphoma-an evolving concept
K S Kurz, A Zamo, C Drewes, et al.
Vaccines
|
July 29, 2023
Serologic Response and Safety after a Third Dose of the COVID-19 BNT162b2 Vaccine in Patients with Inflammatory Bowel Diseases
Hadar Edelman-Klapper, Keren Masha Rabinowitz, Eran Zittan, et al.
Annals of Hematology
|
August 1, 2020
First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A-results of a retrospective analysis
M Pouyiourou, A Meyer, A Stroux, et al.
Blood Advances
|
September 17, 2020
Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models
Stefan Alig, Vindi Jurinovic, Mohammad Shahrokh Esfahani, et al.
Page
of 116
Search research articles
Search
Showing results (1041-1050 of 1,153) with videos related to
Sort By:
Page
of 116
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2017
Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group
Annette M Staiger, Marita Ziepert, Heike Horn, et al.
Nature Medicine
|
November 25, 2014
Disruption of the PRKCD-FBXO25-HAX-1 axis attenuates the apoptotic response and drives lymphomagenesis
Ursula Baumann, Vanesa Fernández-Sáiz, Martina Rudelius, et al.
Leukemia & Lymphoma
|
August 26, 2017
Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYC
Ulrike Paul, Julia Richter, Christiane Stuhlmann-Laiesz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 29, 2019
Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration
Joshua W D Tobin, Colm Keane, Jay Gunawardana, et al.
Mbio
|
April 30, 2026
The Guild Model of CF Airway Microbial Ecology
Sage J B Dunham, Gregory A Willkeen, Ben Darby, et al.
Genes, Chromosomes & Cancer
|
July 16, 2015
The PCBP1 gene encoding poly(rC) binding protein I is recurrently mutated in Burkitt lymphoma
Rabea Wagener, Sietse M Aukema, Matthias Schlesner, et al.
Leukemia
|
November 7, 2025
Cyclin D1 rearranged diffuse large B-cell lymphoma-an evolving concept
K S Kurz, A Zamo, C Drewes, et al.
Vaccines
|
July 29, 2023
Serologic Response and Safety after a Third Dose of the COVID-19 BNT162b2 Vaccine in Patients with Inflammatory Bowel Diseases
Hadar Edelman-Klapper, Keren Masha Rabinowitz, Eran Zittan, et al.
Annals of Hematology
|
August 1, 2020
First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A-results of a retrospective analysis
M Pouyiourou, A Meyer, A Stroux, et al.
Blood Advances
|
September 17, 2020
Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk models
Stefan Alig, Vindi Jurinovic, Mohammad Shahrokh Esfahani, et al.
Page
of 116